Newsfeed

This area is a possible form of presentation for the integration of news sources relating to listed companies.
The presentation level is a template based on short news services, where users can get a quick overview of the latest news. The detailed views enable further research if interested.

This newsfeed is a compilation of current news from direct connections of TopTier NewsWire services related to listed companies. This feed is for demonstration purposes only. Sector-specific news, public relations and product information can be accessed via the GICS portals > Sector Intelligence section.

US4330001060
Reset filter
Do you already know our new terminal view? Click here.
FIGI: BBG00Q53VYM7
HIMS
Hims & Hers Health Inc
GICS: Health Care · SECTOR: EQTY · SUB-SECTOR: Household & Personal Products · THEMEFOLIO: $HLTH
NAME
Hims & Hers Health Inc
ISIN
US4330001060
TICKER
HIMS
MIC
XNYS
REUTERS
HIMS.N
BLOOMBERG
HIMS US
Thu, 07.08.2025       Hims & Hers Health
US4330001060

NEW YORK, Aug. 7, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Hims & Hers Health, Inc. (NYSE: HIMS). Shareholders who purchased shares of HIMS during the class period listed are encour...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Wed, 06.08.2025       Hims & Hers Health
US4330001060

LOS ANGELES, Aug. 6, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Hims & Hers Health, Inc. ("Hims" or the "Company") (NYSE: HIMS) have opportunity to lead the securities fraud class action lawsuit....
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Wed, 06.08.2025       Hims & Hers Health
US4330001060

NEW YORK, Aug. 6, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Wed, 06.08.2025       Hims & Hers Health
US4330001060

NEW YORK, Aug. 6, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Tue, 05.08.2025       Hims & Hers Health
US4330001060

NEW YORK, Aug. 5, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Hims & Hers Health, Inc. ("Hims & Hers Health, Inc." or the "Company") (NYSE: HIMS) of a class action securities lawsuit. CLASS DEFINITI...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Mon, 04.08.2025       Hims & Hers Health
US4330001060

NEW YORK, Aug. 4, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Hims & Hers Health, Inc. (NYSE: HIMS). Shareholders who purchased shares of HIMS during the class period listed are encour...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Sun, 03.08.2025       Hims & Hers Health
US4330001060

NEW YORK, Aug. 3, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Hims & Hers Health, Inc. (NYSE: HIMS) between April 29, 2025 and June 23, 2025, both dates inc...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Sun, 03.08.2025       Hims & Hers Health
US4330001060

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Hims To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Hims between April 29, 2025 and June 22, 2025 and would like to discuss your legal rights, call Faruqi & Faru...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Sat, 02.08.2025       Hims & Hers Health
US4330001060

NEW YORK and NEW ORLEANS, Aug. 1, 2025 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until August 25, 2025 to file lead plaintiff applications in securities class action lawsuits against Hims & Hers Health, Inc. ("Hims" or the "Co...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Fri, 01.08.2025       Hims & Hers Health
US4330001060

RADNOR, Pa., Aug. 1, 2025 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that securities class action lawsuits have been filed in the United States District Court for the Northern District of California against Hims & Hers Health, Inc. ("Hims & Hers") (NYSE: HIMS) on behalf of those...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Silent Ad
Fri, 01.08.2025       Hims & Hers Health
US4330001060

NEW YORK, Aug. 1, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Hims & Hers Health, Inc. ("Hims & Hers Health, Inc." or the "Company") (NYSE: HIMS) of a class action securities lawsuit. CLASS DEFINITI...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Thu, 31.07.2025       Hims & Hers Health
US4330001060

BENSALEM, Pa., July 31, 2025 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Hims & Hers Health, Inc. ("Hims" or the "Company") (NYSE: HIMS). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN HIMS & HERS HEALTH, INC....
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Thu, 31.07.2025       Hims & Hers Health
US4330001060

NEW YORK, July 31, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Tue, 29.07.2025       Hims & Hers Health
US4330001060

NEW YORK, July 29, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Hims & Hers Health, Inc. (NYSE: HIMS) between April 29, 2025 and June 23, 2025, both dates in...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Tue, 29.07.2025       Hims & Hers Health
US4330001060

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Hims To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Hims between April 29, 2025 and June 22, 2025 and would like to discuss your legal rights, call Faruqi & Faru...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Tue, 29.07.2025       Hims & Hers Health
US4330001060

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today released new data showing that its personalized, digital-first approach to weight loss is driving meaningful, sustainable results, laying the groundwork for lasting success. In a first-of-its-kind U.S. analysis of treatment plans, includin...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Tue, 29.07.2025       Hims & Hers Health
US4330001060

NEW YORK, July 29, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Hims & Hers Health, Inc. ("Hims & Hers Health, Inc." or the "Company") (NYSE: HIMS) of a class action securities lawsuit. CLASS DEFINIT...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Mon, 28.07.2025       Hims & Hers Health
US4330001060

LOS ANGELES, July 28, 2025 /PRNewswire/ -- The DJS Law Group announces that it is investigating claims on behalf of investors of Hims & Hers Health, Inc. ("Hims & Hers" or "the Company") (NYSE: HIMS) for violations of the securities laws. INVESTIGATION DETAILS: The investigation focuses on whether the Company issued misleading statements...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Mon, 28.07.2025       Hims & Hers Health
US4330001060

LOS ANGELES, July 28, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Hims & Hers Health, Inc. ("Hims & Hers" or "the Company") (NYSE: HIMS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated ther...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Mon, 28.07.2025       Hims & Hers Health
US4330001060

NEW YORK, July 28, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Hims & Hers Health, Inc. (NYSE: HIMS). Shareholders who purchased shares of HIMS during the class period listed are encou...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Silent Ad
Mon, 28.07.2025       Hims & Hers Health
US4330001060

SAN DIEGO, July 28, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Hims & Hers Health, Inc. (NYSE: HIMS) securities between April 29, 2025 and June 23, 2025, all dates inclusive (the "Class Period"), have until Monday, August 25, 2025 to seek appointment as lead plaintiff of the Hims &...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Mon, 28.07.2025       Hims & Hers Health
US4330001060

RADNOR, Pa., July 27, 2025 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that securities class action lawsuits have been filed in the United States District Court for the Northern District of California against Hims & Hers Health, Inc. ("Hims & Hers") (NYSE: HIMS) on behalf of thos...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Sun, 27.07.2025       Hims & Hers Health
US4330001060

NEW YORK, July 27, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Sat, 26.07.2025       Hims & Hers Health
US4330001060

NEW ORLEANS, July 25, 2025 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until August 25, 2025 to file lead plaintiff applications in securities class action lawsuits against Hims & Hers Health, Inc. ("Hims" or the "Company") (NYSE: HIMS), if they purchased the Company's securities betwe...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Fri, 25.07.2025       Hims & Hers Health
US4330001060

NEW YORK, July 25, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Hims & Hers Health, Inc. ("Hims & Hers Health, Inc." or the "Company") (NYSE: HIMS) of a class action securities lawsuit. CLASS DEFINIT...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Thu, 24.07.2025       Hims & Hers Health
US4330001060

LOS ANGELES, July 24, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Hims & Hers Health, Inc. ("Hims" or the "Company") (NYSE: HIMS)....
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Thu, 24.07.2025       Hims & Hers Health
US4330001060

NEW YORK, July 24, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Hims & Hers Health, Inc. (NYSE: HIMS). Shareholders who purchased shares of HIMS during the class period listed are encou...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Wed, 23.07.2025       Hims & Hers Health
US4330001060

PHILADELPHIA, July 23, 2025 /PRNewswire/ -- Berger Montague announces a securities fraud investigation into Hims & Hers Health Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS) concerning potential violations of the Securities Exchange Act of 1934. The inquiry focuses on whether investors were misled about the Company's regulatory compli...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Wed, 23.07.2025       Hims & Hers Health
US4330001060

LOS ANGELES, July 23, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Hims & Hers Health, Inc. ("Hims" or the "Company") (NYSE: HIMS) have opportunity to lead the securities fraud class action lawsuit....
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Wed, 23.07.2025       Hims & Hers Health
US4330001060

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Hims To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Hims between April 29, 2025 and June 22, 2025 and would like to discuss your legal rights, call Faruqi & Faru...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Tue, 22.07.2025       Hims & Hers Health
US4330001060

RADNOR, Pa., July 22, 2025 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that securities class action lawsuits have been filed in the United States District Court for the Northern District of California against Hims & Hers Health, Inc. ("Hims & Hers") (NYSE: HIMS) on behalf of thos...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Tue, 22.07.2025       Hims & Hers Health
US4330001060

NEW YORK, July 22, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Tue, 22.07.2025       Hims & Hers Health
US4330001060

NEW YORK, July 22, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Hims & Hers Health, Inc. ("Hims & Hers Health, Inc." or the "Company") (NYSE: HIMS) of a class action securities lawsuit. CLASS DEFINIT...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Mon, 21.07.2025       Hims & Hers Health
US4330001060

NEW YORK, July 21, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Hims & Hers Health, Inc. (NYSE: HIMS). Shareholders who purchased shares of HIMS during the class period listed are encou...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Sat, 19.07.2025       Hims & Hers Health
US4330001060

NEW YORK, July 19, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Hims & Hers Health, Inc. (NYSE: HIMS) between April 29, 2025 and June 23, 2025, both dates in...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Sat, 19.07.2025       Hims & Hers Health
US4330001060

NEW YORK and NEW ORLEANS, July 18, 2025 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until August 25, 2025 to file lead plaintiff applications in securities class action lawsuits against Hims & Hers Health, Inc. ("Hims" or the "C...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Fri, 18.07.2025       Hims & Hers Health
US4330001060

NEW YORK, July 18, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Hims & Hers Health, Inc. ("Hims & Hers Health, Inc." or the "Company") (NYSE: HIMS) of a class action securities lawsuit. CLASS DEFINIT...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Thu, 17.07.2025       Hims & Hers Health
US4330001060

RADNOR, Pa., July 17, 2025 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that securities class action lawsuits have been filed in the United States District Court for the Northern District of California against Hims & Hers Health, Inc. ("Hims & Hers") (NYSE: HIMS) on behalf of thos...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Thu, 17.07.2025       Hims & Hers Health
US4330001060

BENSALEM, Pa., July 17, 2025 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Hims & Hers Health, Inc. ("Hims" or the "Company") (NYSE: HIMS). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN HIMS & HERS HEALTH, INC....
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Thu, 17.07.2025       Hims & Hers Health
US4330001060

NEW YORK, July 17, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Thu, 17.07.2025       Hims & Hers Health
US4330001060

NEW YORK, July 17, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Hims & Hers Health, Inc. (NYSE: HIMS). Shareholders who purchased shares of HIMS during the class period listed are encou...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Wed, 16.07.2025       Hims & Hers Health
US4330001060

PHILADELPHIA, July 16, 2025 /PRNewswire/ -- Berger Montague announces a securities fraud investigation into Hims & Hers Health Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS) concerning potential violations of the Securities Exchange Act of 1934. The inquiry focuses on whether investors were misled about the Company's regulatory compli...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Wed, 16.07.2025       Hims & Hers Health
US4330001060

SAN DIEGO, July 16, 2025 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Hims & Hers Health, Inc. (NYSE: HIMS) securities between April 29, 2025 and June 23, 2025, both dates inclusive (the "Class Period"), have until Monday, August 25, 2025 to seek appointment as lead plaintiff o...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Tue, 15.07.2025       Hims & Hers Health
US4330001060

LOS ANGELES, July 15, 2025 /PRNewswire/ -- The DJS Law Group announces that it is investigating claims on behalf of investors of Hims & Hers Health, Inc. ("Hims & Hers" or "the Company") (NYSE: HIMS) for violations of the securities laws. INVESTIGATION DETAILS: The investigation focuses on whether the Company issued misleading statements...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Tue, 15.07.2025       Hims & Hers Health
US4330001060

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Hims To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Hims between April 29, 2025 and June 22, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wil...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Tue, 15.07.2025       Hims & Hers Health
US4330001060

NEW YORK, July 15, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Hims & Hers Health, Inc. ("Hims & Hers Health, Inc." or the "Company") (NYSE: HIMS) of a class action securities lawsuit. CLASS DEFINIT...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Tue, 15.07.2025       Hims & Hers Health
US4330001060

LOS ANGELES, July 15, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Hims & Hers Health, Inc. ("Hims & Hers" or "the Company") (NYSE: HIMS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated ther...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Mon, 14.07.2025       Hims & Hers Health
US4330001060

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced that it will report second quarter 2025 financial results after the market closes on Monday, August 4, 2025. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day. The conference call...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Mon, 14.07.2025       Hims & Hers Health
US4330001060

NEW YORK, July 14, 2025 /PRNewswire/ --  Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Hims & Hers Health, Inc. (NYSE: HIMS) between April 29, 2025 and June 23, 2025, both dates i...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Mon, 14.07.2025       Hims & Hers Health
US4330001060

NEW YORK, July 14, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Hims & Hers Health, Inc. (NYSE: HIMS). Shareholders who purchased shares of HIMS during the class period listed are encou...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink